在癌症治疗中,抗体-药物结合剂组合
Giulia Pretelli1, Kleida Mati2, Lucia Motta3,4
1Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
Exploration of targeted anti-tumor therapy
|July 5, 2024
概括
抗体-药物合物 (ADC) 在癌症治疗中表现有前途,但面临挑战. 将ADC与其他疗法结合使用可能会改善治疗结果并克服耐药性,这是未来研究的一个关键领域.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 是一种重要的抗癌药物.
- 虽然12种ADC已获得FDA批准,2种已被撤销,许多正在临床开发中.
- 抗癌药物表现出抗瘤活性,但具有不良事件和耐药性的挑战.
研究的目的:
- 审查目前的ADC与其他抗瘤药物的组合.
- 描述ADC组合疗法的最新进展.
- 概述ADC组合策略的未来方向.
主要方法:
- 临床试验和临床前研究的文献综述.
- 分析涉及ADC和药物,如化疗,免疫检查点抑制剂,单克隆抗体和向药物的组合疗法.
- 综合了关于疗效,安全性和耐药性机制的数据.
主要成果:
- 抗癌剂与其他抗癌剂的组合正在众多临床试验中积极研究.
- 有希望的结果表明,在各种瘤类型中,潜在的协同效应和改善治疗结果.
- 目前的研究强调了组合疗法的潜力,以提高ADC的疗效和管理耐药性.
结论:
- ADC组合疗法是一个快速发展的领域,具有显著的治疗潜力.
- 需要进一步的研究来优化组合策略和克服临床挑战.
- 未来的方向包括探索新的组合和个性化治疗方法,以加强癌症治疗.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
